
Windlas Biotech Ltd is Rated Sell
2026-04-23 10:10:41Windlas Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Windlas Biotech Ltd Surges 7.09% to Day's High of Rs 875.45 — Outperforms Sector by 5.15 Percentage Points
2026-04-15 10:31:27The Sensex advanced 1.79% on 15 Apr 2026, yet Windlas Biotech Ltd outpaced the broader market with a 7.09% gain, touching an intraday high of Rs 875.45. This 5.15-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a mere market tailwind.
Read More
Windlas Biotech Ltd is Rated Sell
2026-04-12 10:10:23Windlas Biotech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 05 Feb 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 12 April 2026, providing investors with the latest insights into its performance and outlook.
Read More
Windlas Biotech Ltd is Rated Sell
2026-04-01 10:10:03Windlas Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read MoreWindlas Biotech Gains 5.32%: 2 Key Factors Driving This Week’s Momentum
2026-03-28 11:03:07Key Events This Week 23 Mar: Valuation shifts to fair amid sector comparisons 27 Mar: Technical momentum shifts amid mixed market signals 27 Mar: Week closes at Rs.765.45 (+5.32%) outperforming Sensex Week OpenRs.726.80 Week CloseRs.765.45+5.32% <div class="stat-item...
Read More
Windlas Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-03-27 08:03:05Windlas Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent upgrade from Hold to Sell by MarketsMOJO on 4 February 2026, the stock’s price action and technical indicators suggest a cautiously evolving outlook for investors.
Read MoreWindlas Biotech’s Mixed Week: +0.01% Price, -0.28% Sensex Tell the Story
2026-03-21 12:01:03Key Events This Week 16 Mar: Stock hits 52-week low at Rs.699.35 amid continued downtrend 17 Mar: Price rebounds sharply by 2.21% to Rs.724.15 18 Mar: Further gains of 1.12% to Rs.732.25 19 Mar: Sharp decline of 1.99% to Rs.717.65 on heavy market sell-off 20 Mar: Recovery with 1.27% gain to close at Rs.726.80 Week OpenRs.726.75 ...
Read More
Windlas Biotech Ltd is Rated Sell
2026-03-21 10:10:03Windlas Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read MoreAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
28-May-2026 | Source : BSEQ4 & FY26 Earnings Conference Call Transcript
Compliances-Reg.24(A)-Annual Secretarial Compliance
26-May-2026 | Source : BSEAnnual Secretarial Compliance Report for the financial year ended March 31 2026
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Recording Of Conference Call
22-May-2026 | Source : BSEAudio recording of Investors/ Analyst conference call on the audited consolidated and standalone financial results of the Company for the quarter and financial year ended March 31 2026.
Corporate Actions
No Upcoming Board Meetings
Windlas Biotech Ltd has declared 116% dividend, ex-date: 21 Jul 25
No Splits history available
No Bonus history available
No Rights history available